Transforming growth factor /3 (TGF (3),t originally isolated from platelets as a 25-kD peptide (1, 2), has been shown to be a product of other inflammatory cells, including lymphocytes (3, 4) and macrophages (5, 6), and to have potent immunomodulatory effects (7). Although five different forms of TGFJ3 have now been characterized (1), only TGF01 and its homologue, TGF02 (8, 9), have thus far been identified in hemopoietic cells (6). Each ofthese peptides has been cloned, demonstrating that TGF01 is encoded as a 390 amino acid precursor (10), TGFs2 as a 412 amino acid precursor (11, 12) , and that both have a signal peptide of 20-23 amino acids at the NH2 terminus . The processed 112 amino acid chains of the two peptides share 72% sequence homology and appear to bind equally well to TGFS class III receptors (13), although TGFS1 binds with greater affinity than TGF02 to class I and II receptors (14, 15). Interestingly, lymphoid cells appear to possess only class I and II TGF,6 receptors (16), although in vitro, lymphocyte and monocyte responses to TGF01 and 02 appear comparable (6, 17, 18) . The secretion of TGFa peptides by lymphocytes and monocytes only after activation (3-6) implicates these polypeptides in the evolution of immunologic processes, and in recent studies TGFR has been identified in chronic inflammatory tissues (19) (20) (21) (22) , including the synovium of rheumatoid arthritis patients (7, 22) and in experimentally induced arthritis in rodents (22). To define the role of TGFS in such lesions, we injected natural or recombinant TGF0 directly into the joint cavity of Lewis rats and monitored its effect on cellular recruitment and activation, and on its potential modulation of pathogenic effects. TGF01 and TGF02 were both found to induce synovial erythema, swelling, and leukocyte infiltration . The infiltrating mononuclear cells, activated to express growth factors, likely regulated the pronounced synovial hyperplasia that was apparent within 2-3 d. Based on these observations, it appears that TGF0, released by platelets and inflammatory cells in the arthritic synovium, may directly contribute to the events associated with inflammatory arthropathies.
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Products, Stone Mountain, GA) and quantitated with an Optomax Image Analyzer (Optomax, Hollis, NH). Chemotactic activity is defined as the mean (t SEM) number ofcells that migrated through the 5-,um pores in three standard fields for each of triplicate filters.
Dermal fibroblasts were obtained and subcultured as reported (28) . Fibroblast chemotaxis was also determined in 48-well microchamber plates using 8-Am PVP-free polycarbonate filters . The fibroblasts (2.5 x 105/ml) were incubated for 150 min at 37°C, the filters removed, stained, and counted as above.
IL-1 Assay. Cell-free supernatants (twofold dilutions) were assayed for IL-1 activity using thymocytes from 6-8-wk-old C3H/HeJ mice as described (25) . The cultures werepulsed with 0.5 ACi/well [3H]TdR (specific activity 1.9 Ci/mmol; Schwarz-Mann, Orangeburg, NY) for the final 5 h of incubation and the incorporated radioactivity was determined. Data were transformed into units by comparison to an IL-1 standard containing 100 Units/ml (Genzyme Corp., Boston, MA) .
TNFAssay. Cell-free supernatants were assayed for TNF by the L929 cytotoxicity assay (29) . rTNF (gift of Cetus Corp., San Francisco, CA) was used as the standard against which the samples, diluted twofold, were compared.
Fibroblast Proliferation Assay. Primary synovial fibroblast cultures were established from the synovium ofbacterial cell wall-injected Lewis rats (30) after enzymatic dissociation with collagenase (50 U/ml; Worthington Biochemical Corp., Freehold, NJ) . Fibroblasts were cultured at 5 x 104 cells/ml/well in 24-well flat-bottomed plates in DME alone (controls) or DME containing 5% normal rat serum (NRS) and TGF01 or TGF/32 (0-20 ng/ml) at 37°C for 48 h. Additionally, fibroblasts were cultured in the presence of diluted cell-free supernatants derived from TGF$-stimulated monocytes . 4 h before harvest, the cultures were pulsed with 1 uCi/ml [3H]TdR and proliferation was quantitated by the level of incorporation of [3H]TdR in triplicate wells .
RNA Isolation and Northern Analysis. Total RNA was isolated from 15 x 106 PEC cultured for 4 h with media, TGF,Q1, TGF02, or rTGF0l (1-30 ng/ml) or from excised synovial tissues by the acid guanidinium thiocyanate-phenol-chloroform extraction procedure (31) . For Northern blots, 5 hg total RNA was fractionated on 1 .0% agarose gels containing formaldehyde and transferred to nitrocellulose filters. The blots were prehybridized for 4 h and then hybridized overnight with 31 P-labeled cDNA probes . Probes included IL-10 cDNA (32), the cDNA probe for mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (33) , and the cDNA probe for human TGFal (10) . The filters were washed and were exposed to Kodak XAR film with intensifier screens at -70°C for 4-48 h.
Results
Clinical Manifestations of i.a. 71GF--0 Injection . Within 12-24 h after the initial injection of 1 Ag of natural TGF#1 or its homologue, TGF-/32, significant swelling and erythema became apparent in the treated joints. Two additional injections caused further exacerbation of the response, which reached an Al of 3.6 t 0.5 for TGF01 and a maximum 4.0 for TGF#2 on the third day (Fig. 1) . A similar administratioñ Induction ofjoint swelling and erythema by TGFS. Lewis rats received 3 daily i. a. injections of 1 tag ofTGF/31, TGF02, rTGF#l or vehicle only. AI were determined at 24 h and daily thereafter. Data represent the meanjoint scoresofseven tonine animals in each group.
of rTGF S1 induced a parallel arthritic response achieving an Al of 4 within 2-3 d. Since a maximal AI was obtained after three injections, treatment was stopped and the course of the synovitis monitored for an additional 3 wk. As shown in Fig. 1 , the acute swelling and erythema induced by natural TGF01 and 02 declined within 7-10 d, whereas the response to the recombinant peptide persisted for >3 wk, with some clinically apparent swelling evident >6 wk (data not shown) . The mechanism for the prolonged response to rTGF/31 is unclear, since the appropriate vehicle for this preparation induced no clinically apparent inflammatory response when injected into the contralateraljoint (Fig. 1) , nor did the vehicles for the natural TGF01 and (32.
Since the rTGF01 induced a more pronounced clinical response than the natural products, we compared the ability of various dilutions of the recombinant peptide to cause clinically evident synovitis. As shown in Fig. 2 , a single injection of 0 .01 or 0.1 wg rTGF (31 was ineffective in stimulating synovitis as compared with the 1.0 wg injection of TGF01. However, after a second injection at these lower concentrations, significant articular indices were evident, even for 0.01 14g amounts. After the third and final injection, the AI peaked and then began to decline, reaching baseline by 9 d (0.1 and 0.01 ttg injections), except for the 1.0 ttg injection regimen for which the AI persisted after 9 d (see also Fig. 1 ).
Histological Manifestations of 7UGF--J3 Injection .
Because of the pronounced clinical response in thejoints to the local administration ofTGF(3, subsequent studies evaluated the histopathogenesis of these lesions within the synovium . Whereas the synovium ofnormal joints is represented by a thin layer of synovial lining cells underlaid by loose adipose and connective tissue stroma (Fig . 3 A) , within hours after the local administration ofTGF/31 or (32 the accumulation of inflammatory cells became apparent in the synovial space (Fig. 3 B) and within the synovial tissue (Fig. 3 C) . This recruitment ofinflammatory cells included some neutrophils with significantly larger numbers ofmononuclear cells. Furthermore, many ofthe mononuclear phagocytes appeared highly activated with large vacuoles and enlarged cytoplasm (Fig .  3 B) . Interestingly, the cellular constituents ofthe TGF0-induced lesions at 24-48 h were similar to what has been observed in synovial tissues 2-3 wk after the onset of antigen-induced arthritis (25) . Associated with the accumulating mononuclear infiltrate was an increase in synovial fibroblast-like cells and an apparent angiogenic response by day 2-3 after initiation of TGF-a treatment (Fig. 3 , D, E) . Synovial fibroblast accumulation was likely due to recruitment because of the rapidity of the response, but was also associated with a proliferative response of local cells as evidenced by the presence of mitotic figures (Fig . 3 E) . After cessation of TGF-0 administration, the numbers of mononuclear cells gradually declined in parallel with the clinically apparent decrease in swelling and distortion of the joints . Fibroplasia however, persisted, although at reduced levels, and in the rTGF 0-treated joints, enhanced cellularity persisted for 3-4 wk. The nature of the prolonged effect of rTGF 01 as compared with the natural peptides was not readily apparent . The appropriate vehicle-injected contralateral joints were not characterized by a cellular infiltrate, although occasional hemorrhage due to injection trauma was seen .
During the evolution of the synovial inflammation and hyperplasia of synovial fibroblast-like cells, no apparent evidence of erosion of the connective tissue structures occurred . In contrast, the synovial tissue demonstrated deposition of new connective matrix by the recruited fibroblast population (Fig . 3, D, E) .
Identification ofMononuclear Cell Subpopulations. To specifically define the infiltrating mononuclear cells in the TGFa-injected synovium, the tissues were stained with cell-specific mAbs by immunoperoxidase . As shown in Fig. 4 , after a single TGF(3 injection, intense staining occurred with an antibody that recognizes rat monocytes/macrophages (ED1) (34) , indicating that the majority of infiltrating leukocytes were of monocytic lineage. In contrast, there were few ED1 + cells in the thin synovial lining of the vehicle only-treated joints (Fig . 4 A) . In addition, the majority of these mononuclear phagocytes were Ia', indicative of in situ activation and differentiation (Fig . 4 E) . Some Ia+ cells, which were also ED1 -on sequential sections, were also seen in the normal synovium . A proportion of the infiltrating mononuclear cells appeared to be lymphocytes as indicated by the levels of OX19 staining (Fig . 4,F) . No apparent differences in the relative numbers of these cellular phenotypes were observed between the tissues injected with TGFal, TGFQ2, or rTGF-/31 . UltrastructuralAnalysis of 7LF-,l3-treatedSynovium . The impressive cellular response to the local administration of TGF0 prompted us to further characterize these tissues at the ultrastructural level. The normal synovial lining layer consists of 1 or 2 layers ofrelatively flattened cells (Fig. 5 A) . After i.a. injection of TGF0, the lining showed increased thickness and cellularity, with the cells appearing rounded and more ac- tive (Fig. 5 B) . Furthermore, the underlying matrix, which was relatively acellular in the controls, became infiltrated with cells and the collagen bundles appeared disrupted (Fig. 5, A, B) . As defined at the light microscopic level and further by immunocytochemical analysis, the underlying tissue was infiltrated by many cells ofmonocytic lineage (Fig. 6, A, B, C) . Numerous examples were found ofan apparent intimate relationship between these monocytic cells and fibroblast-like cells (Fig. 6, A, B) , as well as an association between mononuclear cells and mitotic cells, presumably fibroblasts (Fig. 6 C) . Interestingly, an increased population of mast cells was observed in the TGF/3-treated synovial tissues (Fig. 7) . Monocyte and Fibroblast Chemotaxis to TGF-f3 . The predominant effects of local administration of TGF9 to the synovium appeared to be monocyte recruitment and activation, fibroblast recruitment and proliferation, and the deposition of extracellular matrix . Our next series of experiments, therefore, focused on delineating in vitro the mechanisms whereby TGF0 might be mediating these tissue responses. Natural TGFf31, recently shown to be a potent chemoattractant for human peripheral blood monocytes (35, 36) was assayed for its ability to induce rat monocyte-macrophage chemotaxis in an in vitro assay in parallel with TGFfl2 and the recombinant form ofTGFf31. TGFfl1, whether natural or recombinant, induced peripheral blood monocyte (Fig. 8 ) and peritoneal macrophage (data not shown) chemotaxis at 0.1 pg/ml. Furthermore, TGFX82, not previously tested for chemotactic activity, induced a parallel response in the in vitro assay, consistent with its in vivo ability to initiate monocyte recruitment into the synovium. As previously shown for human fibroblasts (37), TGFf3-stimulated rodent fibroblast chemotaxis at femtomolar concentrations in an in vitro assay (Fig. 9) . Monocyte chemotactic activity of TGF-(3 . Rat peripheral blood monocytes (1 .1 x 106/ml) were assayed for their ability to respond to TGFX41, TGF02, and rTGF-01 at the indicated concentrations . The data represent the mean number of monocytes that migrated in three fields for triplicate filters (nine determinations/ point) . Standard errors were routinely <10% of the mean and data are representative of four experiments . Fibroblast chemotaxis to TGF0 . Dermal fibroblasts (2 .5 x 105/ml) were assayed in vitro for chemotactic responsiveness to TGFsl at the indicated concentrations . Data represent the mean t SEM fibroblasts per field for triplicate filters.
Direct andIndirect Effects of TGF-0 on Fibroblast Proliferation. In addition to the recruitment of fibroblasts into the synovium, the increased fibroblast population was also attributed to proliferation as evidenced by the increased frequency ofmitotic figures (Figs. 3 E and 6 C) . To determine whether TGF(3 was directly mitogenic for synovial fibroblasts, fibroblasts were cultured in the presence or absence of TGFa and proliferation monitored by incorporation of [3H]TdR into DNA (Table I ). The addition ofTGF-0 to serum-free cultures offibroblasts did not induce fibroblast proliferation and furthermore, the addition of TGF-0 to proliferating fibroblasts (NRS-induced) often suppressed the proliferative response. These data suggested that the TGF/3-mediated fibroblast proliferative response in vivo might be mediated indirectly, possibly through induction of monocyte growth factor production . In fact, TGFR added to monocyte cultures stimulated these cells to release products capable of stimulating fibroblast proliferation (Table I) .
Induction of IL-1 Production by TGF-0 In Vitro and In Vioo. One monocyte product that can influence fibroblast growth is IL-1, and therefore we evaluated the effects of TGF(3 on the induction of IL-1 . Messenger RNA was obtained from PEC ex- Fibroblast Proliferation In Vitro ' Synovial fibroblasts (5 x 10 4 /ml) were cultured without (DME) or with 5% NRS to which was added 0-20 ng/ml TGF-#1 .
x Fibroblasts were cultured in the presence of cell-free supernatants obtained from rat monocytes that had been stimulated for 36 h with 0-20 ng/ml TGF-01 or TGF-p2 . posed to TGF-#1 or ,82 in vitro and probed with a cDNA probe for IL-1/3 ( Fig. 10  A) . After 4 h, IL-1/3 steady-state mRNA levels were elevated in TGF-a1-or TGF-(32-treated cell cultures . The induction of ILl-0 mRNA was concentration dependent with augmentation at 1 ng/ml and increasing mRNA levels at higher concentrations . Constitutively expressed GAPDH levels were not altered by TGF/3. In parallel cultures, 36-h supernatants were assayed for IL-1 bioactivity (Fig. 10  B) . At 1 ng/ml TGF-01 or TGFfl2, IL-1 could be detected in the monocyte supernatants with increased levels at 10-20 ng/ml TGF#. Aliquots ofthese culture supernatants were also assayed for TNF, another monocyte product with pleiotropic effects in inflammation and repair. A similar concentration-dependent induction of TNF was observed in response to either TGFa1 or TGF02 (data not shown), indicating that TGF(3 is an effective inducer of IL-1, TNF, and likely other monocyte-derived growth factors (6) .
Because of the ability ofTGFfl to stimulate monocytes to produce growth factors such as IL-1 in vitro, we processed synovial tissue obtained after TGF a administration to determine whether TGFP was similarly active in vivo. As demonstrated in Fig. 11 , TGF,6 not only was an effective inducer of IL-lei message in vitro, but also were cultured at 10 6/ml in the presence or absence of 1-20 ng/ml TGF01 or TGFS2. Cell-free supernatants were harvested at 36 h and assayed for IL-1 levels in the thymocyte costimulator assay. Units were determined by comparison with a standard curve with 100 U/ml IL-1 .
in vivo. Synovial tissue obtained 24 h after a single injection of TGF R, which is characterized by an infiltrate of activated (Ia') monocytic cells, expressed significantly elevated steady-state levels of IL-1/3. Furthermore, mRNA levels of TGF (31 were also elevated in these tissues indicating autoinduction ofTGF0. In addition to the 2.4-kb mRNA ofTGF0, a recently identified 1 .9-kb transcript (38) was also apparent in the TGF/3-injected synovial tissues, but not in the control synovium. Discussion The potential ofTGF0 to initiate synovial inflammation was examined by direct injection of recombinant or natural TGF,61 or natural TGFa2 into the synovial space ofrat hind anklejoints . Each form of TGF0 rapidly induced a profound synovitis. Administration of as little as 20 ng rTGF01 initiated an inflammatory response in the synovium . Early events included edema and leukocyte infiltration . Within 24 h after the first injection, mononuclear cells were the dominant infiltrating inflammatory cell and immunohistochemical analysis indicated that they were primarily Ia+ macrophages. Lesser numbers of T lymphocytes (0X19+) were detected . Increased cellularity of the synovial lining layer and fibroblast proliferation in the synovial connective tissue were also apparent, and expansion ofthe fibroblast population and deposition of collagen continued over the entire period of peptide administration. At the apex (days 3-4) of the response, the formation of new capillaries was FIGURE 11 . Induction of IL-1# and TGF01 gene expression in synovium by TGFS. RNA was isolated from synovial tissue 24 h after a single i.a. injection of TGFS or vehicle. After extraction, the mRNA was analyzed by RNA hybridization with 32 P-labeled IL-1# and TGF0I .
discernable. Both the mononuclear cell infiltration and the associated fibrosis were reversible when i.a. injection of TGFR was discontinued .
The complement of events induced by TGF0 was remarkable in its complexity and diversity. Some, but not all, of the events can be ascribed to the direct activities of TGF0. For example, TGFS has been shown to be approximately three orders of magnitude more potent than C5a as a chemoattractant for human monocytes (35, 36) , and as shown in the present study, TGFal, TGF02, and rTGF-(31 are also chemotactic for rat monocytes. Thus, it appears likely that the mononuclear cell infiltration seen in the synovium after i.a. injection of TGFa largely reflects the direct chemoattraction of monocytes and/or tissue macrophages by these peptides . However, the possibility that TGF9 might also induce additional chemotactic signals in vivo cannot be excluded . Although TGFa has not been shown to be chemotactic for T lymphocytes, the appearance of T cells after TGF(3 administration may indicate the induction oflymphocyte chemoattractants such as IL-8 (39) . Furthermore, TGFS is directly chemotactic for fibroblasts (37) (Fig. 9 ) that increase in number soon after TGF0 administration.
Other sequelae of i.a. TGFS cannot as readily be attributed to direct activity of this cytokine . For example, fibroblast and endothelial cell proliferation is inhibited, not promoted, by TGF0 in culture (reviewed in reference 1). It seems probable, therefore, that other signals, induced in situ by TGFS, may also play important roles in the development of TGFQ-induced synovial pathology. In this regard, it has been recently reported that TGF01 and -02, at picomolar concentrations, induce human monocytes to express several cytokines including IL-1/3, TNFa, plateletderived growth factor (PDGF), and basic fibroblast growth factor (bFGF) (6) . In the present study, we report that whereas TGF01 and TGF02 were not directly mitogenic for synovial fibroblasts, supernatants from TGFail-and TGFR2-stimulated rat monocyte/macrophages did stimulate synovial fibroblast growth. These supernatants contained significant levels ofIL-10 and TNFa, and Northern blot analysis demonstrated induction ofthe specific mRNA for IL-1/3. Consistent with this in vitro observation was the elevation of IL-1/3 mRNA in the synovial tissue within 24 h after TGF(3 administration . Furthermore, these synovial tissues expressed increased message levels for TGFX31, implicating an autoinduction of this peptide that may further promote mononuclear cell recruitment and activation . Of interest is the identification of the recently described 1.9-kb species of the TGF01 mRNA, the function of which is unknown, but which has been linked to conditions of tissue injury and inflammation (20, 38) .
Several studies have documented that TGF-/3 promotes connective tissue matrix synthesis by fibroblasts in vitro and in vivo. However, induction of monokine synthesis by TGF0 may also contribute to regulation of fibroblast matrix component synthesis (reviewed in reference 1). In this regard, analysis ofthe mRNA from TGF-0-injected synovium revealed a marked increase in type I procollagen mRNA (Manthey, C., unpublished observation) consistent with the morphological identification of matrix deposition in these tissues. TGF(3 also suppresses the expression of proteases while promoting the synthesis of protease inhibitors (40) contributing to the profibrotic influence of this peptide.
It is noteworthy that in contrast to the pannus invasion and destruction of cartilage and bone that is characteristic of streptococcal cell wall (SCW)-induced arthritis in this rat model, the synovitis induced by TGF0 eventually resolves with no evidence of permanent pathologic alterations of the joint. However, the transient nature of the TGF(3 stimulus administered in these studies may not be reflective of the chronic lesions in antigen-induced arthritis and the continued presence of TGF0 and other cytokines that promote pannus formation and tissue erosion. Thus, although TGF-0 may be a key mediator of the events associated with SCW-induced arthritis, we cannot determine in these studies whether it is a causative factor in joint destruction. Intriguing indirect support for a protective role for TGF(3 in SCWinduced arthritis is the suggestion that retinoids, which are effective in suppressing SCW-induced joint destruction (41; Allen, J. B., H. L. Wong, G. L. Costa, and S. M. Wahl, manuscript in preparation), may exert some of their biological actions through the induction of TGF0 (1). TGF0 has been identified not only in the tissues, but in the synovial effusions ofpatients with rheumatoid arthritis (18, 22, 42) . Thus, the contribution of TGF-/3 to the pathogenesis and/or regulation of this disease is as yet speculative, since the potent immunosuppressive actions of TGF0 (7), coupled with its ability to promote tissue healing (43) , suggest that it may be beneficial, whereas the ability ofTGF9 to promote inflammation through its effects on mononuclear phagocytes (7) implicates this peptide as a pathogenic factor. Summary After intraarticular injection of TGF(31 or TGF(32, marked swelling and erythema of the injected joints were apparent within 12-24 h. On a scale of 0 to 4, by day 3, the TGF-R-treated joints had articular indices (AI) of 3.6 t 0.5 to 4.0 t 0.0 compared with no response for the vehicle-injected contralateral joints . Histopathologic evaluation revealed a predominantly mononuclear phagocyte infiltrate with some neutrophils and T lymphocytes, consistent with active inflammation . The monocytic pattern of leukocyte infiltration at 2-3 d was comparable to that seen in animals with antigen-induced arthritis after 2-3 wk. Extensive synovial fibroblast hyperplasia became apparent within 48 h, likely as a result of TGF(3 induction of growth factor synthesis by the accumulating monocytes . TGF(32, a homologue of TGF (31, was found to induce a similar level of synovitis and synovial hyperplasia consistent with its parallel monocyte and fibroblast chemotactic properties and ability to induce transcription and translation of monocyte/macrophage-derived growth factors . These data suggest that TGF0, released by platelets and activated inflammatory cells, may play a direct role in leukocyte recruitment and activation in arthritic and other chronic inflammatory lesions .
